Inverse Agonism and Neutral Antagonism at a Constitutively Active Alpha-1a Adrenoceptor

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2000 Oct 4

PMID 11015306

Citations 12

Authors

J Zhu

T Taniguchi

R Takauji

F Suzuki

T Tanaka

I Muramatsu

Affiliations

Soon will be listed here.

Abstract

We have studied the antagonist action of prazosin and KMD-3213 in a constitutively active mutant of the human alpha-1a adrenoceptor in which Ala(271) was substituted to Thr and was expressed in CHO cells. Inverse agonism was characterized by up-regulation of receptor density, a decrease in basal GTPgammaS binding, and a reduction in basal inositol-1,4,5-trisphosphate (IP(3)) level. According to the above criteria, prazosin acted as an inverse agonist, whilst KMD-3213 behaved as a neutral antagonist. Compared with the wild-type receptor, mutant receptor exhibited single affinity sites for [(3)H]-prazosin, [(3)H]-KMD and the non-radioactive ligands tested, and displayed significantly higher affinities for several agonists but not for the two antagonists. Administration of KMD-3213 to prazosin-treated CHO cells expressing the mutant receptor reversed the inverse agonism of prazosin resulting in rapid increases in cellular IP(3), in intracellular [Ca(2+)] and in the rate of extracellular acidification. These results indicated that a neutral antagonist can reverse the action of an inverse agonist at the receptor site. The distinct properties of inverse agonist and neutral antagonist in affecting receptor function may be important for the clinical use of such antagonists.

Citing Articles

The Role of the Paraventricular-Coerulear Network on the Programming of Hypertension by Prenatal Undernutrition.

Cayupe B, Troncoso B, Morgan C, Saez-Briones P, Sotomayor-Zarate R, Constandil L Int J Mol Sci. 2022; 23(19).

PMID: 36233268 PMC: 9569920. DOI: 10.3390/ijms231911965.

Hypertension in Prenatally Undernourished Young-Adult Rats Is Maintained by Tonic Reciprocal Paraventricular-Coerulear Excitatory Interactions.

Cayupe B, Morgan C, Puentes G, Valladares L, Burgos H, Castillo A Molecules. 2021; 26(12).

PMID: 34207980 PMC: 8230629. DOI: 10.3390/molecules26123568.

A Systematic Review of Inverse Agonism at Adrenoceptor Subtypes.

Michel M, Michel-Reher M, Hein P Cells. 2020; 9(9).

PMID: 32825009 PMC: 7564766. DOI: 10.3390/cells9091923.

Probing the correlation between ligand efficacy and conformational diversity at the α-adrenoreceptor reveals allosteric coupling of its microswitches.

Wu F, Williams L, Abdul-Ridha A, Gunatilaka A, Vaid T, Kocan M J Biol Chem. 2020; 295(21):7404-7417.

PMID: 32303636 PMC: 7247315. DOI: 10.1074/jbc.RA120.012842.

Evidence for altered brain reactivity to norepinephrine in Veterans with a history of traumatic stress.

Hendrickson R, Raskind M, Millard S, Sikkema C, Terry G, Pagulayan K Neurobiol Stress. 2018; 8:103-111.

PMID: 29888305 PMC: 5991318. DOI: 10.1016/j.ynstr.2018.03.001.

References

Lefkowitz R, Cotecchia S, Samama P, Costa T . Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol Sci. 1993; 14(8):303-7. DOI: 10.1016/0165-6147(93)90048-O. View

Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J . Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993; 365(6447):649-51. DOI: 10.1038/365649a0. View

Chidiac P, Hebert T, Valiquette M, Dennis M, Bouvier M . Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol. 1994; 45(3):490-9. View

Barker E, WESTPHAL R, Schmidt D, Sanders-Bush E . Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands. J Biol Chem. 1994; 269(16):11687-90. View

Milano C, Dolber P, Rockman H, Bond R, Venable M, Allen L . Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994; 91(21):10109-13. PMC: 44967. DOI: 10.1073/pnas.91.21.10109. View

Minneman K, Theroux T, Hollinger S, Han C, Esbenshade T . Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol. 1994; 46(5):929-36. View

Bond R, Leff P, Johnson T, Milano C, Rockman H, McMinn T . Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature. 1995; 374(6519):272-6. DOI: 10.1038/374272a0. View

Hwa J, Perez D . The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation. J Biol Chem. 1996; 271(11):6322-7. DOI: 10.1074/jbc.271.11.6322. View

Graham R, Perez D, Hwa J, Piascik M . alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. Circ Res. 1996; 78(5):737-49. DOI: 10.1161/01.res.78.5.737. View

10.

Smit M, Leurs R, Alewijnse A, Blauw J, van Nieuw Amerongen G, van de Vrede Y . Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc Natl Acad Sci U S A. 1996; 93(13):6802-7. PMC: 39108. DOI: 10.1073/pnas.93.13.6802. View

11.

Kenakin T . The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev. 1996; 48(3):413-63. View

12.

MacEwan D, Milligan G . Inverse agonist-induced up-regulation of the human beta2-adrenoceptor in transfected neuroblastoma X glioma hybrid cells. Mol Pharmacol. 1996; 50(6):1479-86. View

13.

Newman-Tancredi A, Conte C, Chaput C, Spedding M, Millan M . Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635. Br J Pharmacol. 1997; 120(5):737-9. PMC: 1564555. DOI: 10.1038/sj.bjp.0701025. View

14.

Lee T, Cotecchia S, Milligan G . Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists. Biochem J. 1997; 325 ( Pt 3):733-9. PMC: 1218618. DOI: 10.1042/bj3250733. View

15.

Muramatsu I, Murata S, Isaka M, Piao H, Zhu J, Suzuki F . Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues. Life Sci. 1998; 62(17-18):1461-5. DOI: 10.1016/s0024-3205(98)00090-3. View

16.

Shryock J, Ozeck M, Belardinelli L . Inverse agonists and neutral antagonists of recombinant human A1 adenosine receptors stably expressed in Chinese hamster ovary cells. Mol Pharmacol. 1998; 53(5):886-93. View

17.

Garcia-Sainz J . Modulation of basal intracellular calcium by inverse agonists and phorbol myristate acetate in rat-1 fibroblasts stably expressing alpha1d-adrenoceptors. FEBS Lett. 1999; 443(3):277-81. DOI: 10.1016/s0014-5793(98)01738-4. View

18.

Taniguchi T, Inagaki R, Murata S, AKIBA I, Muramatsu I . Microphysiometric analysis of human alpha1a-adrenoceptor expressed in Chinese hamster ovary cells. Br J Pharmacol. 1999; 127(4):962-8. PMC: 1566087. DOI: 10.1038/sj.bjp.0702609. View

19.

Rossier O, Abuin L, Fanelli F, Leonardi A, Cotecchia S . Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes. Mol Pharmacol. 1999; 56(5):858-66. DOI: 10.1124/mol.56.5.858. View

20.

Suzuki F, Taniguchi T, Takauji R, Murata S, Muramatsu I . Splice isoforms of alpha(1a)-adrenoceptor in rabbit. Br J Pharmacol. 2000; 129(8):1569-76. PMC: 1572000. DOI: 10.1038/sj.bjp.0703242. View